Tasigna Atherosclerosis Lawsuit News

You Can Sue Novartis If You Have Developed Atherosclerosis-Related Conditions After Taking Tasigna

Innocent people have been the victim of Novartis failing to warn American doctors of the extended risks of using the anti-cancer chemotherapy drug Tasigna

Friday, August 11, 2017 - Because of the risks of strokes, heart attacks, amputations and instant death associated with the taking of the anti-cancer drug Tasigna, US health officials have forced the company to place the most serious drug warning possible, a "Black Box Warning" label on containers of the drug. The label warns "prolonged QT sudden death reported." Prolonged QT prolongation simply is an abnormal heart rate that will likely result in heart attack.

If you are currently being treated for cancer with Tasigna, your doctor should be actively monitoring you for signs of atherosclerosis-related conditions. Tasigna patients should have regular electrocardiograms (ECG) to test signs of heart abnormality before during and after Tasigna treatments. Those taking Tasigna should look for the feeling of chest tightness and pain, light-headedness, arm or leg weakness, or heart palpitations. Patients fearing atherosclerosis often experience leg abnormalities such as pain, tingling, numbness, swelling or weakness when walking or climbing stairs. Another sign of atherosclerosis could be discoloration and swelling of the toes and feet. Have your blood pressure checked as well as high blood pressure is a clear indication that you may be experiencing arterial blockage.

The side effects of taking Tasigna should not be taken lightly as people have suffered and died as a result of the anti-cancer chemotherapy treatment. Tasigna patients should consider any or all of the above symptoms to be an indication that a serious, life-threatening blood chemistry problem has developed and to seek immediate medical attention. Your oncologist should know by now that people with Tasigna-related atherosclerosis develop peripheral artery disease, strokes, heart attacks and possibly instant death, and he/she should follow the warning to more closely monitor their Tasigna patient's general health.

If you have developed atherosclerosis or any of the other health complications stemming from taking Tasigna you are right to feel angry. Tasigna patients just like you from all 50 states are suing Novartis International AG because they have been left with unpaid medical bills, lost wages and are suffering from chronic, severe pain. Many develop full-blown peripheral artery disease, suffer heart attacks, and strokes and some Tasigna cancer patients have had to have the amputation of a foot or leg as a result of taking the deadly, mislabeled drug.

Those suing Novartis allege that American cancer health care professionals were unaware of the Canadian Health warning that Tasigna causes peripheral artery disease for years after the company alerted Canada that there was a connection. Plaintiffs claim that Novartis made an intentional business decision to protect their multi-million dollar US market by continuing to aggressively market the drug in the US long after knowing of the drug's deadly side effects. Novartis was also the target of the wrath of the American Food and Drug Administration for its underhanded marketing schemes of fake companies, bribery, and cash incentives and the company was forced to pay $390 million of the $1.7 billion in fines the US agency levied against them.

More Recent Tasigna Atherosclerosis Lawsuit News:

Lawyers for Tasigna Atherosclerosis Lawsuits

Attorneys handling Tasigna lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Tasigna lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Tasigna lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.